K. Torneke et al., A COMPARISON BETWEEN CLENBUTEROL, SALBUTAMOL AND TERBUTALINE IN RELATION TO RECEPTOR-BINDING AND IN-VITRO RELAXATION OF EQUINE TRACHEAL MUSCLE, Journal of veterinary pharmacology and therapeutics, 21(5), 1998, pp. 388-392
Beta(2)-adrenoceptor agonists are used as bronchodilators in both huma
ns and horses. Of these drugs, clenbuterol is the one most frequently
used when treating chronic obstructive pulmonary disease in the horse,
while salbutamol and terbutaline are used in the treatment of human a
sthma, Little is known of the properties of the latter two drugs in eq
uine medicine. We have compared salbutamol and terbutaline with clenbu
terol in relation to their ability to relax muscle strips from equine
tracheal muscle, precontracted with 40 nM carbachol, in tissue chamber
s, The affinities of these drugs to the beta(2)-adrenoceptors in homog
enates of the same muscle tissue were also examined. These experiments
were performed with radioligand binding studies using the very potent
beta-adrenoceptor antagonist I-125-cyanopindolol. The three drugs wer
e almost equipotent in relaxing the muscle strips. The EC50-values for
salbutamol, terbutaline and clenbuterol were 5.6, 13.8 and 2.1 nM, re
spectively, and all three drugs relaxed the preparations completely. I
n the competitive binding study, however, the K-d-value of clenbuterol
was much lower (24 nM) than that of salbutamol and terbutaline (1100
nM and 3900 nM, respectively). The amount of receptors bound at the EC
50-value of clenbuterol was 8% compared to less than 1% for salbutamol
and terbutaline. This indicates a lower intrinsic efficacy of clenbut
erol than of the other two drugs. The beta-adrenoceptor density was 45
+/- 14.3 fmol/mg protein (mean +/- SD) and the K-d-value of I-125-cya
nopindolol was 11.4 +/- 3.3 pM.